Intelligent Bio Solutions Inc.
INBS
$6.14
-$0.85-12.16%
NASDAQ
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Revenue | 1.11M | 843.90K | 728.90K | 607.50K | 872.30K |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 1.11M | 843.90K | 728.90K | 607.50K | 872.30K |
| Cost of Revenue | 593.50K | 508.30K | 387.50K | 384.40K | 525.50K |
| Gross Profit | 518.30K | 335.60K | 341.40K | 223.10K | 346.80K |
| SG&A Expenses | 2.66M | 2.72M | 2.41M | 1.81M | 1.95M |
| Depreciation & Amortization | 303.40K | 300.30K | 302.00K | 305.20K | 300.40K |
| Other Operating Expenses | -193.30K | -383.90K | -173.30K | -133.60K | -126.10K |
| Total Operating Expenses | 3.85M | 3.73M | 3.28M | 2.87M | 3.60M |
| Operating Income | -2.74M | -2.88M | -2.55M | -2.26M | -2.73M |
| Income Before Tax | -3.00M | -3.10M | -2.55M | -2.26M | -2.69M |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -3.00M | -3.10M | -2.55M | -2.26M | -2.69M |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | 12.00K | 12.50K | 7.10K | 7.30K | 9.20K |
| Net Income | -2.98M | -3.09M | -2.54M | -2.25M | -2.69M |
| EBIT | -2.74M | -2.88M | -2.55M | -2.26M | -2.73M |
| EBITDA | -2.48M | -2.64M | -2.32M | -2.02M | -2.48M |
| EPS Basic | -3.49 | -4.42 | -4.41 | -4.96 | -7.05 |
| Normalized Basic EPS | -1.98 | -2.56 | -2.75 | -3.09 | -4.40 |
| EPS Diluted | -3.49 | -4.42 | -4.41 | -4.96 | -7.05 |
| Normalized Diluted EPS | -1.98 | -2.56 | -2.75 | -3.09 | -4.40 |
| Average Basic Shares Outstanding | 854.70K | 699.90K | 577.20K | 453.60K | 381.10K |
| Average Diluted Shares Outstanding | 854.70K | 699.90K | 577.20K | 453.60K | 381.10K |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |